Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kwang Y Chin"'
Autor:
Louise Kostos, James P. Buteau, Theresa Yeung, Juliana Di Iulio, Jing Xie, Anthony Cardin, Kwang Y. Chin, Brittany Emmerson, Katie L. Owen, Belinda S. Parker, Heidi Fettke, Luc Furic, Arun A. Azad, Michael S. Hofman
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background[177Lu]Lu-PSMA is a radioligand therapy used in metastatic castration-resistant prostate cancer (mCRPC). Despite a survival benefit, the responses for many patients receiving [177Lu]Lu-PSMA are not durable, and all patients eventually devel
Externí odkaz:
https://doaj.org/article/ee75493d95874a12b67e6d0f0cb88f42
Publikováno v:
Abdominal Radiology. 46:2770-2778
Multiparametric magnetic resonance imaging (mpMRI) of the prostate is increasingly used for the preoperative detection and staging of prostate cancer. Image quality of prostate mpMRI can be significantly degraded by motion related artefact due to bow
Autor:
Louise Kathleen Kostos, James Patrick Buteau, Theresa Yeung, Sophia Xie, Juliana Di Iulio, Anthony Cardin, Katie Owen, Heidi Fettke, Kwang Y Chin, Brittany Emmerson, Mohammad B Haskali, Belinda Parker, Luc Furic, Arun Azad, Michael S Hofman
Publikováno v:
Journal of Clinical Oncology. 41:TPS280-TPS280
TPS280 Background: [177Lu]Lu-PSMA-I&T (LuPSMA) is a small molecule radioligand that delivers radiation via beta-particulate emission to cells expressing prostate-specific membrane antigen (PSMA). Despite a survival benefit in mCRPC, responses for man
Publikováno v:
Abdominal radiology (New York). 46(6)
Multiparametric magnetic resonance imaging (mpMRI) of the prostate is increasingly used for the preoperative detection and staging of prostate cancer. Image quality of prostate mpMRI can be significantly degraded by motion related artefact due to bow
Autor:
Mohamad Hamady, Kwang Y. Chin, Catherine M. Jones, Ara Darzi, Thanos Athanasiou, Guang-Zhong Yang
Publikováno v:
Seminars in Ultrasound, CT and MRI. 29:214-222
Coronary in-stent restenosis (ISR) and thrombosis cause recurrent cardiac ischemia, require repeat investigations, and have significant clinical and financial implications. As coronary stenting becomes widespread, the number of patients with recurren